首页> 外文期刊>Journal of Pharmaceutical and Biomedical Analysis: An International Journal on All Drug-Related Topics in Pharmaceutical, Biomedical and Clinical Analysis >N-(4-nitro-2,1,3-benzoxadiazoyl-7-yl)-N-methyl-2-aminoacetohydrazide (NBD-CO-Hz) as a precolumn fluorescent derivatization reagent for carboxylic acids in high-performance liquid chromatography.
【24h】

N-(4-nitro-2,1,3-benzoxadiazoyl-7-yl)-N-methyl-2-aminoacetohydrazide (NBD-CO-Hz) as a precolumn fluorescent derivatization reagent for carboxylic acids in high-performance liquid chromatography.

机译:N-(4-硝基-2,1,3-苯并恶二唑基-7-基)-N-甲基-2-氨基乙酰肼(NBD-CO-Hz)作为高效液相色谱中羧酸的柱前荧光衍生试剂。

获取原文
获取原文并翻译 | 示例
           

摘要

A new fluorescent reagent for carboxylic acids, N-(4-nitro-2,1,3-benzoxadiazoyl-7-yl)-N-methyl-2-aminoacetohydr azide (NBD-CO-Hz) was synthesized and its applicability as a precolumn derivatization reagent in high-performance liquid chromatography was examined. NBD-CO-Hz reacted with 2-arylpropionic acids (2-APAs), a group of non-steroidal antiinflammatory drugs (NSAIDs) in the presence of a condensing agent, 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC) and pyridine at room temperature for 2 h to give fluorescent adducts. The reaction solution was subjected to a reversed phase or a chiral stationary phase HPLC and the derivatives were detected fluorometrically at a wavelength of 530 nm with an excitation of 475 nm. The detection limits were in the fmol range on column.
机译:合成了一种新型的羧酸荧光试剂N-(4-硝基-2,1,3-苯并恶二唑基-7-基)-N-甲基-2-氨基乙酸酐叠氮化物(NBD-CO-Hz),其可作为在高效液相色谱中检查了柱前衍生试剂。 NBD-CO-Hz在缩合剂1-乙基-3-(3-二甲基氨基丙基)碳二亚胺(EDC)存在下与一组非甾体抗炎药(NSAIDs)2-芳基丙酸(2-APA)反应)和吡啶在室温下放置2 h,得到荧光加合物。对反应溶液进行反相或手性固定相HPLC,并且在475nm的激发波长下在530nm的波长下用荧光法检测衍生物。检测限在柱上的fmol范围内。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号